SAMD7 Inhibitors
Chemical inhibitors of SAMD7 utilize various mechanisms to impede its function within cellular processes. Palbociclib, for instance, targets CDK4/6, essential kinases for cell cycle progression, which are necessary for the proliferation of cells expressing SAMD7. By inhibiting these kinases, Palbociclib indirectly reduces the involvement of SAMD7 in cell cycle-regulated processes. Similarly, Trichostatin A, an HDAC inhibitor, modifies chromatin structure and gene expression, which can disrupt the functional interactions of SAMD7 with chromatin. Another compound, MG-132, impedes the proteasome's ability to degrade ubiquitinated proteins, potentially leading to the accumulation of proteins that regulate SAMD7's functions.
Further inhibitors such as LY294002 and Wortmannin exert their effects by inhibiting PI3K, affecting the PI3K/Akt pathway involved in crucial cellular functions that SAMD7 may regulate. Rapamycin targets the mTOR pathway, downregulating effectors involved in SAMD7-associated growth and metabolism pathways. Kinase activity is crucial for many cellular signaling pathways, and Staurosporine broadly inhibits kinases, which could interrupt SAMD7's activity if it relies on phosphorylation. Inhibitors specific to MAPK pathways, such as U0126, SB203580, PD98059, and SP600125, target various components such as MEK1/2, p38 MAPK, and JNK. These inhibitors prevent the activation of key signaling proteins upstream of SAMD7, which are integral to its functional role in cellular signaling. Lastly, Y-27632 disrupts the Rho/ROCK pathway, which can impede SAMD7's role in processes like motility and proliferation, highlighting the diverse strategies through which these chemical inhibitors can modulate SAMD7's function within cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib specifically inhibits CDK4/6, which are crucial for cell cycle progression. By inhibiting these kinases, the proliferation of cells expressing SAMD7 is hindered, leading to functional inhibition of SAMD7 by reducing its involvement in cell cycle regulated processes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an inhibitor of histone deacetylases (HDAC). HDAC inhibition can result in altered chromatin structure and gene expression profiles. Given SAMD7's potential role in gene regulation through chromatin modification, HDAC inhibition could disrupt SAMD7's functional interactions with chromatin. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a proteasome inhibitor that can prevent the degradation of ubiquitinated proteins. If SAMD7 is involved in pathways that are regulated by protein degradation, proteasome inhibition could lead to the functional inhibition of SAMD7 by accumulation of regulatory proteins that are normally degraded. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can disrupt the PI3K/Akt signaling pathway. This pathway is involved in various cellular processes, including growth and survival. Inhibition of PI3K can lead to reduced phosphorylation and activation of proteins that may interact with or regulate SAMD7, resulting in its functional inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a central regulator of cell growth and metabolism. Inhibiting mTOR can result in the downregulation of downstream effectors that are required for SAMD7's function in growth and metabolism-related processes, thereby inhibiting the protein's function. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent kinase inhibitor that can inhibit a broad spectrum of kinases. It can inhibit the function of SAMD7 by disrupting kinase-dependent signaling pathways that SAMD7 is involved in, particularly if SAMD7 requires phosphorylation for its activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 selectively inhibits MEK1/2, which are upstream of ERK in the MAPK pathway. By inhibiting MEK, the activation of ERK and its downstream signaling, which may include pathways involving SAMD7, is disrupted, leading to functional inhibition of SAMD7. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAPK. The p38 MAPK pathway is involved in stress responses, and inhibition of p38 MAPK can impair the functional role of SAMD7 in responding to cellular stress signals. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that blocks the activation of ERK. Since SAMD7 may be involved in pathways that are regulated by ERK signaling, blocking ERK activation can result in the functional inhibition of SAMD7. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is part of the MAPK signaling pathways. JNK inhibition can affect transcription factors and other proteins that interact with SAMD7, leading to its functional inhibition. | ||||||